Developer docs
API playgroundTry for free, no card

Search company profiles

Smoore Technology Indonesia

Full company profile

uuid005c4ao

Namestring
Smoore Technology Indonesia
Legal namestring
思摩尔国际控股有限公司
Company typeenum
Public
Founded yearint
2009
Descriptiontext

Smoore International Holdings Limited (HKEX: 06969.HK) is a Shenzhen-headquartered, globally dominant electronic atomization technology company founded in 2009. It designs and manufactures atomization hardware spanning ceramic heating (FEELM), electromagnetic solid-state atomization (METEX), and leak-proof architectures, holding 6,816 patent applications as of June 2023 with 1,400+ R&D experts including 100+ PhDs. The company operates a 7,200-UPH fully automated atomizer production line — the world's highest — and holds 16.5% global market share as the largest e-vapor device manufacturer.

The company generates revenue through three business models: (1) B2B ODM/OEM manufacturing of closed-system e-vapor devices, heat-not-burn components, and special-purpose atomization products for global tobacco majors including Imperial Tobacco and PMI, plus independent e-vapor brands; (2) own-brand consumer sales through VAPORESSO (40 million+ users, 40,000+ retail stores across 50+ countries), FEELM, and MOYAL — a skincare atomization brand launched in the US in October 2024 via DTC e-commerce; (3) R&D services leveraging its atomization platform for external clients including pharmaceutical partners such as AIM Immuno Tech for inhaled Ampligen drug delivery. Customers span global tobacco companies, independent e-vapor brands, pharmaceutical companies, and premium skincare consumers, with pricing negotiated bilaterally in B2B and through direct retail in B2C.

The company is incorporated in Hong Kong, with primary operating entity Smoore Technology (Shenzhen) Co., Ltd., and maintains a regional presence via a London European representative office. Smoore Technology Indonesia, with 604 employees in Malang, Jawa Timur, appears to operate as a regional subsidiary supporting manufacturing or sales within the group's global footprint. The parent group became the first e-vapor company to have science-based carbon targets validated by SBTi in June 2025.

Short descriptiontext

Smoore International (06969.HK) is a Shenzhen-based global atomization technology platform serving tobacco OEMs, consumer vaping brands, pharmaceutical partners, and skincare consumers through B2B manufacturing, own-brand retail, and R&D services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersShenzhen, China
HQ citystring
Shenzhen
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electronic atomization devices, ceramic heating technology, vapor manufacturing services, inhalation drug delivery, transdermal skincare devices
Industry1 code
PRIMARYCRADAJAF
Electronic Nicotine Delivery Systems (ENDS/Vapes) Devices Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
Product category
Electronic Atomization Devices
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Manufacturing (ODM/OEM)
TypeHardware Sales
Description

Research, design and manufacture of closed-system electronic atomization products, heat-not-burn products, and special-purpose atomization product components for global leading tobacco companies (including Imperial Brands and PMI), independent e-vapor companies and other enterprise clients.

smooreholdings.com
2Own Brand Consumer Sales
TypeHardware Sales
Description

Research, design, manufacture and sale of proprietary brand electronic atomization products (VAPORESSO, FEELM) and atomization beauty products (MOYAL) to retail consumers through direct-to-consumer e-commerce and global retail networks.

smooreholdings.com
3R&D Services
TypeProfessional Services
Description

Research and development services based on atomization technology reserves provided to external clients, including medical/pharmaceutical applications.

smooreholdings.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1FEELM
Description

High-end vaporization technology brand based on global ceramic heating technology, combining taste restoration technology and innovative electronic technology for high-quality closed electronic vaporization solutions

smooreholdings.com
+3 more records
Core offering1 text field

Smoore designs, develops and manufactures electronic atomization devices across three business segments: (1) B2B ODM/OEM production of closed-system e-vapor products, heat-not-burn devices and atomization components for global tobacco companies and independent e-vapor brands; (2) own-brand consumer hardware sold under VAPORESSO, FEELM, METEX and MOYAL labels; and (3) R&D services licensing its atomization technology platform to pharmaceutical partners for inhaled drug delivery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 16.5% global market share as world's largest e-vapor device manufacturer
+5 more records
Product overview1 text field

SMOORE is a global atomization technology solutions provider operating through three main business segments: Atomization Transmission (electronic atomization devices through FEELM and VAPORESSO brands), Atomization Medical, and Atomization Beauty. The company's product portfolio includes FEELM (ceramic-based closed electronic atomization technology brand), VAPORESSO (high-end consumer brand), METEX (solid atomization technology), and MOYAL (skincare atomization brand). SMOORE provides both B2B manufacturing services for global tobacco companies and B2C branded products to consumers worldwide.

Product and service5 records
1FEELM
CategoryClosed-system e-vapor atomization technology (B2B)
Description

FEELM is Smoore's high-end ceramic-heating atomization technology brand, combining flavor restoration technology and innovative electronics to deliver high-quality closed-system e-vapor solutions. It is sold B2B to global tobacco and e-vapor companies and licensed across 50+ countries.

2VAPORESSO
CategoryConsumer vaping hardware (B2C)
Description

VAPORESSO is Smoore's owned consumer vaping hardware brand, selling pod systems, open-system devices and disposable products through 40,000+ certified retail stores and brand channels to 40M+ global users. Products carry CRC Canada, TPD Europe and KC Korea certifications.

3METEX
CategorySolid-state atomization technology
Description

METEX is Smoore's solid-state atomization technology brand, providing technology and product solutions for different solid atomization media based on resistive and electromagnetic heating platforms with precise temperature control.

4MOYAL
CategorySkincare atomization hardware (B2C)
Description

MOYAL is Smoore's premium skincare atomization brand, using patented two-phase gas-liquid atomization technology to convert serums into microparticles for deeper transdermal delivery. Sold direct-to-consumer in the US via www.MoyalBeauty.com as the Lanshi Superconducting Gun device plus matched serums.

5Inhalation Drug Delivery Device Platform
CategoryPharmaceutical R&D services and medical device co-development
Description

Smoore provides R&D services and co-development of self-administered aerosolized drug delivery devices for pharmaceutical partners, leveraging its atomization technology platform. The flagship engagement is with AIM Immuno Tech for inhaled delivery of Ampligen (targeting ME/CFS and COVID-19 applications).

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-04-06
Description

Smoore International signed a material transfer and research agreement with AIM Immuno Tech on April 6, 2020, to develop an inhaled drug delivery device using Smoore's aerosol inhalation technology for AIM's Ampligen drug. Ampligen has received approval in Argentina for ME/CFS and completed Phase 3 clinical trials in the US. The partnership targets COVID-19 treatment applications and aligns with Smoore's strategy to expand into the medical/pharmaceutical sector. AIM's Chief Science Officer Dr. David Strayer noted the goal of developing a self-administered inhaled device that can safely deliver aerosolized Ampligen deep into lung airways.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1NJOY
TypeDirect peer
Description

NJOY is a US-focused vaping device competitor that has received FDA marketing authorization for e-vapor products, positioning it as a direct competitor in regulated markets and a comparable hardware-focused player.

TypeEmerging player
Description

Aptar is a leader in drug delivery devices including inhalation platforms; relevant as an adjacent competitor and potential partner for Smoore's emerging medical atomization business (e.g., AIM Immuno Tech collaboration).

TypeBroad incumbent
Description

PMI is both a named strategic customer of Smoore for closed-system e-vapor and a competitor through its IQOS heat-not-burn platform — a major global tobacco incumbent with vertically integrated RRP investments.

TypeDirect peer
Description

Innokin is a competing vaping device manufacturer with comparable product categories (open and closed systems) targeting similar consumer and OEM markets globally, representing direct competition in the hardware category.

TypeDirect peer
Description

RELX is one of the largest closed-system e-vapor companies globally and Smoore's most direct competitor in the vaping device category, with comparable target customers, technology platform, and Asia-centric footprint.

TypeBroad incumbent
Description

Imperial Brands is a named key B2B customer of Smoore and a major global tobacco company also developing its own RRP portfolio — overlapping customer/supplier dynamic similar to PMI.

TypeBroad incumbent
Description

BAT is a major global tobacco incumbent with competing RRP products including Vuse (e-vapor) and Glo (heat-not-burn), positioning it as both a potential customer and a competitor to Smoore in the reduced-risk product category.

TypeBroad incumbent
Description

Altria is a major US tobacco incumbent and competitor in the RRP space through its NJOY investment and on! nicotine pouches — with potential to source from or compete with Smoore for OEM/ODM partnerships.

TypeBroad incumbent
Description

JT International is a major global tobacco incumbent with Ploom heat-not-burn products — both a potential B2B customer for Smoore's atomization manufacturing and a competitor in the RRP category across Asian and European markets.

TypeOthers
Description

West Pharmaceutical provides drug delivery components and containment solutions — an adjacent player relevant to Smoore's emerging medical inhalation drug delivery business and a potential ecosystem participant.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Smoore Technology Indonesia

Electronic Atomization Devicessmooreholdings.com

Smoore International (06969.HK) is a Shenzhen-based global atomization technology platform serving tobacco OEMs, consumer vaping brands, pharmaceutical partners, and skincare consumers through B2B manufacturing, own-brand retail, and R&D services.

What Smoore Technology Indonesia does

Smoore International Holdings Limited (HKEX: 06969.HK) is a Shenzhen-headquartered, globally dominant electronic atomization technology company founded in 2009. It designs and manufactures atomization hardware spanning ceramic heating (FEELM), electromagnetic solid-state atomization (METEX), and leak-proof architectures, holding 6,816 patent applications as of June 2023 with 1,400+ R&D experts including 100+ PhDs. The company operates a 7,200-UPH fully automated atomizer production line — the world's highest — and holds 16.5% global market share as the largest e-vapor device manufacturer.

The company generates revenue through three business models: (1) B2B ODM/OEM manufacturing of closed-system e-vapor devices, heat-not-burn components, and special-purpose atomization products for global tobacco majors including Imperial Tobacco and PMI, plus independent e-vapor brands; (2) own-brand consumer sales through VAPORESSO (40 million+ users, 40,000+ retail stores across 50+ countries), FEELM, and MOYAL — a skincare atomization brand launched in the US in October 2024 via DTC e-commerce; (3) R&D services leveraging its atomization platform for external clients including pharmaceutical partners such as AIM Immuno Tech for inhaled Ampligen drug delivery. Customers span global tobacco companies, independent e-vapor brands, pharmaceutical companies, and premium skincare consumers, with pricing negotiated bilaterally in B2B and through direct retail in B2C.

The company is incorporated in Hong Kong, with primary operating entity Smoore Technology (Shenzhen) Co., Ltd., and maintains a regional presence via a London European representative office. Smoore Technology Indonesia, with 604 employees in Malang, Jawa Timur, appears to operate as a regional subsidiary supporting manufacturing or sales within the group's global footprint. The parent group became the first e-vapor company to have science-based carbon targets validated by SBTi in June 2025.

Smoore Technology Indonesia firmographics

Firmographics
Name
Smoore Technology Indonesia
Legal name
思摩尔国际控股有限公司
Website
https://smooreholdings.com
Company type
Public
Founded year
2009
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Smoore International (06969.HK) is a Shenzhen-based global atomization technology platform serving tobacco OEMs, consumer vaping brands, pharmaceutical partners, and skincare consumers through B2B manufacturing, own-brand retail, and R&D services.
Ownership category
akta.pro rank

Smoore Technology Indonesia industry classification

Industry
Product category
Electronic Atomization Devices
akta.pro industry
PRIMARYCRADAJAF
Electronic Nicotine Delivery Systems (ENDS/Vapes) Devices Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands

Keywords

  • Electronic atomization devices
  • Ceramic heating technology
  • Vapor manufacturing services
  • Inhalation drug delivery
  • Transdermal skincare devices

Where Smoore Technology Indonesia is headquartered

Location

Headquarters

HQ city
Shenzhen
HQ country
China
HQ region
Asia

Offices3 records

Markets served

Smoore Technology Indonesia business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Manufacturing (ODM/OEM): Research, design and manufacture of closed-system electronic atomization products, heat-not-burn products, and special-purpose atomization product components for global leading tobacco companies (including Imperial Brands and PMI), independent e-vapor companies and other enterprise clients.
  2. Own Brand Consumer Sales: Research, design, manufacture and sale of proprietary brand electronic atomization products (VAPORESSO, FEELM) and atomization beauty products (MOYAL) to retail consumers through direct-to-consumer e-commerce and global retail networks.
  3. R&D Services: Research and development services based on atomization technology reserves provided to external clients, including medical/pharmaceutical applications.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Smoore Technology Indonesia product offering

Product offering

Core offering

Smoore designs, develops and manufactures electronic atomization devices across three business segments: (1) B2B ODM/OEM production of closed-system e-vapor products, heat-not-burn devices and atomization components for global tobacco companies and independent e-vapor brands; (2) own-brand consumer hardware sold under VAPORESSO, FEELM, METEX and MOYAL labels; and (3) R&D services licensing its atomization technology platform to pharmaceutical partners for inhaled drug delivery.

Product overview

SMOORE is a global atomization technology solutions provider operating through three main business segments: Atomization Transmission (electronic atomization devices through FEELM and VAPORESSO brands), Atomization Medical, and Atomization Beauty. The company's product portfolio includes FEELM (ceramic-based closed electronic atomization technology brand), VAPORESSO (high-end consumer brand), METEX (solid atomization technology), and MOYAL (skincare atomization brand). SMOORE provides both B2B manufacturing services for global tobacco companies and B2C branded products to consumers worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • FEELM: High-end vaporization technology brand based on global ceramic heating technology, combining taste restoration technology and innovative electronic technology for high-quality closed electronic vaporization solutions
  • VAPORESSO
  • METEX
  • MOYAL

Products and services

  • FEELM FEELM is Smoore's high-end ceramic-heating atomization technology brand, combining flavor restoration technology and innovative electronics to deliver high-quality closed-system e-vapor solutions. It is sold B2B to global tobacco and e-vapor companies and licensed across 50+ countries.
  • VAPORESSO VAPORESSO is Smoore's owned consumer vaping hardware brand, selling pod systems, open-system devices and disposable products through 40,000+ certified retail stores and brand channels to 40M+ global users. Products carry CRC Canada, TPD Europe and KC Korea certifications.
  • METEX METEX is Smoore's solid-state atomization technology brand, providing technology and product solutions for different solid atomization media based on resistive and electromagnetic heating platforms with precise temperature control.
  • MOYAL MOYAL is Smoore's premium skincare atomization brand, using patented two-phase gas-liquid atomization technology to convert serums into microparticles for deeper transdermal delivery. Sold direct-to-consumer in the US via www.MoyalBeauty.com as the Lanshi Superconducting Gun device plus matched serums.
  • Inhalation Drug Delivery Device Platform Smoore provides R&D services and co-development of self-administered aerosolized drug delivery devices for pharmaceutical partners, leveraging its atomization technology platform. The flagship engagement is with AIM Immuno Tech for inhaled delivery of Ampligen (targeting ME/CFS and COVID-19 applications).

Quantifiable outcome

  • 16.5% global market share as world's largest e-vapor device manufacturer
  • +5 more outcomes

Companies that use Smoore Technology Indonesia

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Smoore Technology Indonesia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Smoore Technology Indonesia partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AIM Immuno Tech (NYSE: AIM)coreStrategic or Co-development Partner · 6 April 2020Smoore International signed a material transfer and research agreement with AIM Immuno Tech on April 6, 2020, to develop an inhaled drug delivery device using Smoore's aerosol inhalation technology for AIM's Ampligen drug. Ampligen has received approval in Argentina for ME/CFS and completed Phase 3 clinical trials in the US. The partnership targets COVID-19 treatment applications and aligns with Smoore's strategy to expand into the medical/pharmaceutical sector. AIM's Chief Science Officer Dr. David Strayer noted the goal of developing a self-administered inhaled device that can safely deliver aerosolized Ampligen deep into lung airways.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Smoore Technology Indonesia competitors and assessment

Company assessment

Direct peers

  • NJOY: NJOY is a US-focused vaping device competitor that has received FDA marketing authorization for e-vapor products, positioning it as a direct competitor in regulated markets and a comparable hardware-focused player.
  • Innokin Technology: Innokin is a competing vaping device manufacturer with comparable product categories (open and closed systems) targeting similar consumer and OEM markets globally, representing direct competition in the hardware category.
  • RELX Technology: RELX is one of the largest closed-system e-vapor companies globally and Smoore's most direct competitor in the vaping device category, with comparable target customers, technology platform, and Asia-centric footprint.

Emerging players

  • AptarGroup: Aptar is a leader in drug delivery devices including inhalation platforms; relevant as an adjacent competitor and potential partner for Smoore's emerging medical atomization business (e.g., AIM Immuno Tech collaboration).

Broad incumbents

  • Philip Morris International: PMI is both a named strategic customer of Smoore for closed-system e-vapor and a competitor through its IQOS heat-not-burn platform — a major global tobacco incumbent with vertically integrated RRP investments.
  • Imperial Brands: Imperial Brands is a named key B2B customer of Smoore and a major global tobacco company also developing its own RRP portfolio — overlapping customer/supplier dynamic similar to PMI.
  • British American Tobacco: BAT is a major global tobacco incumbent with competing RRP products including Vuse (e-vapor) and Glo (heat-not-burn), positioning it as both a potential customer and a competitor to Smoore in the reduced-risk product category.
  • Altria Group: Altria is a major US tobacco incumbent and competitor in the RRP space through its NJOY investment and on! nicotine pouches — with potential to source from or compete with Smoore for OEM/ODM partnerships.
  • Japan Tobacco International: JT International is a major global tobacco incumbent with Ploom heat-not-burn products — both a potential B2B customer for Smoore's atomization manufacturing and a competitor in the RRP category across Asian and European markets.

Others

  • West Pharmaceutical Services: West Pharmaceutical provides drug delivery components and containment solutions — an adjacent player relevant to Smoore's emerging medical inhalation drug delivery business and a potential ecosystem participant.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat7 records

Key risks4 records

Key highlights6 records

Customer concentration

Smoore Technology Indonesia social profiles

Digital presence

Smoore Technology Indonesia compliance and trust

Trust signal

Compliance6 records

Smoore Technology Indonesia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Smoore Technology Indonesia leadership team

Management profile

Number of profiles

Profiles3 records

Smoore Technology Indonesia subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Smoore Technology Indonesia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Smoore Technology Indonesia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smoore Technology Indonesia

What does Smoore Technology Indonesia do?

Smoore designs, develops and manufactures electronic atomization devices across three business segments: (1) B2B ODM/OEM production of closed-system e-vapor products, heat-not-burn devices and atomization components for global tobacco companies and independent e-vapor brands; (2) own-brand consumer hardware sold under VAPORESSO, FEELM, METEX and MOYAL labels; and (3) R&D services licensing its atomization technology platform to pharmaceutical partners for inhaled drug delivery.

Is Smoore Technology Indonesia a public or private company?

Smoore Technology Indonesia is a public company. It is classified as public and is currently operating.

When was Smoore Technology Indonesia founded?

Smoore Technology Indonesia was founded in 2009. It employs 501 to 1,000 people.

Where is Smoore Technology Indonesia based?

Smoore Technology Indonesia is headquartered in Shenzhen, China, in the Asia region.

How does Smoore Technology Indonesia make money?

Three revenue lines are on record. B2B Manufacturing (ODM/OEM) is the primary driver. The others are own Brand Consumer Sales and R&D Services.

Who are Smoore Technology Indonesia's main competitors?

Direct peers on record are NJOY, Innokin Technology and RELX Technology. AptarGroup is listed as an emerging player. Broad incumbents are Philip Morris International, Imperial Brands, British American Tobacco, Altria Group and Japan Tobacco International. West Pharmaceutical Services is listed as an others.

Does Smoore Technology Indonesia have an API?

No public API is recorded for Smoore Technology Indonesia.

What industry is Smoore Technology Indonesia in?

Smoore Technology Indonesia's product category is Electronic Atomization Devices. Its primary akta.pro industry code is CRADAJAF, Electronic Nicotine Delivery Systems (ENDS/Vapes) Devices Manufacturing & Brands.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StWhat Smoore International Investors Missed Before The FallSmoore International shares fell 43.5% over the past year, trading at HK$8.43. H1 2026 revenue rose to CNY7,208.88m from CNY6,013.29m, but net margin slipped to 7.9% from 8.2%. The company's fair value remains above current price, with a focus on branded platforms and retail data.PrtimesE-Cigarette Stick Market: Driving Next-Gen Device Innovation 2026–2034 – PR TimesSemiconductor Insight published a market research report projecting the global e-cigarette stick market to grow from USD 1.28 billion in 2025 to USD 3.13 billion by 2032, driven by a shift toward harm reduction and tobacco industry diversification. The study highlights key players such as Philip Morris International, Altria Group, and SMORE International, who are investing in technological advancements like smart connected devices and advanced heating elements to capture market share.The Globe and MailAnalysts Are Bullish on These Consumer Goods Stocks: China Mengniu Dairy Co (CIADF), Smoore International Holdings Limited (HK:6969)Analysts SPDB and DBS maintained Buy ratings on China Mengniu Dairy with a price target of HK$23.50 and HK$21.00, respectively, while Guotai Haitong gave a Buy on Smoore International with a HK$13.10 target. Both stocks have Strong Buy consensus, with Mengniu showing 47% upside.BenzingaBig Tobacco Wants Chinese Vapes Banned; Will This Stock Go Up In Smoke?Smoore International Holdings reported a 43.4% drop in first-quarter profit to 192 million yuan, citing increased administrative and R&D spending amid regulatory pressures on its vaping products. Meanwhile, British American Tobacco is lobbying the U.S. government to ban or impose tariffs on disposable vapes made in China to combat illegal market share gains.Tobacco ReporterInnovation InsideSmoore International Holdings, a vaping manufacturer, secured FDA marketing orders for its Njoy Ace and other devices, with FEELM ceramic coils enabling the first pod-style approval. The company holds over 4,300 patents and plans to expand atomization technology into medical and beauty sectors.ReutersCapital Calls: China chokes its vaping startupsChina's Ministry of Industry and Information Technology proposed governing e-cigarettes like tobacco, citing new problems. The move wiped $14 billion off Rlx Technology's market value, halving its capitalization, and rival Smoore's stock fell 27%. The lack of details may have caused an overreaction.